All GLG News Analyses Filed Under: Business of Medicine

How can safety be verified with the Chinese history of contaminants in the toy and food industries.  I certainly would not want to take Chinese drugs. lynn tucker

Although sharing the same address, the hospital from 7 a.m. to 7 p.m. Monday through Friday is a very different hospital during the other 108 hours of the week.  The weekday hospital has a full administrative team, department chairs and service chiefs, experienced nurse managers, and a full complement...

China is already a key supplier for many of the current generics in the Western marketplace today either supplying intermediates or the finished pharmaceutical bulk product.  They are where India was ten to twenty years ago. Now with a better appreciation and experience with FDA and EMEA regulatory...

Any finished medication that a Chinese company tries to bring to the US (or European) market will face tremendous scrutiny.  Look for Indian generic manufacturers (e.g. Ranbaxy, Dr Reddy's) to maintain their competitive edge due to their track record of safety.  Eventually, lower cost generics...

In 1976, sitting in my office in International Marketing at Fisons, Loughborough, UK, I used to watch the drums of bulk paracetamol arriving at the factory from China - easily recognizable from the Chinese script decorating them. I'm sure the UK wasn't the only country importing raw materials from China...

Until Chinese regulations and enforcement catch up with Western consumer standards, the market for Chinese pharmaceuticals will be greatly diminished by its reputation.

1. Goverment, insurers and other payors will undermine investment in new indications if it saves money. 2. Their next direction will be to fund biogeneric and other innovator altneratives. 3. Companies developing high value line extensions must consider formulation management and other strategies...

Low cost generics to be produced in China will lower drug costs.

For too long big pharma has dictated which drugs will come to market and what they will cost.  The entire American healthcare system is literally collapsing because of two costs:  medications and bureacracy.  Expect more payers to look for ways to bring down costs in the fu...

This article warns against "taking testing out of the hands of companies" and warns against the idea that a drug is receiving a Phase 3 trial without early phase testing.  The CATT trial certainly marks a huge change in drug development but what the pharma industry is not appreciating...